Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
KCI, originally Kinetic Concepts, Inc., is a renowned global medical technology company specializing in advanced wound care and specialty surgical solutions. Acquired by 3M in 2019 and integrated into its Medical Solutions Division, KCI's pioneering products, most notably V.A.C.® Therapy, continue to set standards in healing and patient care worldwide. With a rich history of innovation in negative pressure wound therapy and other medical devices, KCI is a cornerstone of 3M's health care business, which is planned to spin off as an independent company named Solventum in 2024.
Serves as a major center for research and development, manufacturing, and administrative functions for 3M's advanced wound care business, leveraging KCI's legacy and expertise.
An expansive campus featuring state-of-the-art research laboratories, engineering facilities, and manufacturing plants dedicated to medical technology innovation.
As part of 3M, the culture fosters innovation, customer-centricity, scientific rigor, and collaboration. It inherits KCI's strong commitment to improving patient outcomes and advancing medical science. This ethos is expected to carry forward with the transition to Solventum.
Historically the global headquarters of KCI, where groundbreaking advancements like V.A.C.® Therapy were developed. It continues to be a vital hub for 3M's (and soon Solventum's) global medical solutions operations and innovation in wound care.
KCI's products and solutions, integrated within 3M's Medical Solutions Division, are available in over 90 countries. Global functions include extensive sales and marketing operations, clinical support and education programs, collaborative research and development initiatives, advanced manufacturing facilities, and comprehensive distribution networks. These ensure that hospitals, clinics, and healthcare providers worldwide have access to KCI's life-changing therapies. This global infrastructure is anticipated to be a core strength of the upcoming independent company, Solventum.
12930 IH 10 West
San Antonio
Texas
USA
Address: 3M Center, St. Paul, MN 55144-1000
Central hub for 3M's global operations, strategy, and corporate governance, influencing all regions where 3M Medical Solutions and KCI products are currently sold.
Address: Garrycastle, Athlone, Co. Westmeath, Ireland
Key manufacturing and distribution center for 3M's (soon Solventum's) medical solutions in the EMEA region, ensuring product availability and support.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, KCI' leadership includes:
KCI has been backed by several prominent investors over the years, including:
The most significant executive news revolves around the formation of Solventum, the planned independent health care company spinning off from 3M. Key leadership roles for Solventum, which will encompass KCI's business, were announced, signaling a new chapter for the advanced wound care leader.
Discover the tools KCI uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
As KCI is part of 3M, employee email addresses typically follow 3M's corporate conventions. Common formats include combinations of first name, last name, or initials with the '@mmm.com' domain. These formats will likely change once Solventum becomes an independent entity with its own domain.
[first_initial][lastname]@mmm.com or [firstname].[lastname]@mmm.com
Format
jdoe@mmm.com or john.doe@mmm.com
Example
85%
Success rate
3M News Center • February 20, 2024
3M announced its Board of Directors has formally approved the planned spin-off of its Health Care business. The new independent company will be named Solventum and will include KCI's advanced wound care portfolio. The separation is targeted for completion on April 1, 2024, with Solventum expected to begin trading on the NYSE....more
Business Wire (3M Press Release) • October 10, 2023
3M showcased new clinical data and research supporting its KCI-branded negative pressure wound therapy (NPWT) products, including the flagship V.A.C.® Therapy system, at the Symposium on Advanced Wound Care (SAWC) Fall 2023. This underscored the ongoing commitment to evidence-based innovation in wound management....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including KCI, are just a search away.